Video

Daniel Hernandez, MD: Culturally Tailored Interventions for Hispanic Patients with RA

Author(s):

Investigators used interviews, performed in a patient’s preferred language and transcribed verbatim, to better uncover and understand what matters most to the Hispanic population.

Daniel Hernandez, MD, explains why the patient perspective is crucial, particularly among Hispanic patients with rheumatoid arthritis (RA), in his American College of Rheumatology Convergence 2022 presentation “Patient Perspective of Unique Support and Education Needs of Latinx/Latino(a)/Hispanic Rheumatoid Arthritis Patients: Implications for a Culturally Tailored and Disease Specific Intervention.” Hernandez is the Director of Medical Affairs and Hispanic Outreach at Global Healthy Living Foundation/CreakyJoints.

Hernandez explained that the study focuses on important factors that the culture itself values, highlighting respect, being personable, trusting those around you, and creating a network, especially that of family members, which a patient can rely on.

“Those concepts are very easy to ignore,” Hernandez stated. “But if you put it front and center, you interview patients, you make sure and you validate that, and if you focus on these types of concepts, you are going to get a more engaging audience.”

Investigators used interviews, performed in a patient’s preferred language and transcribed verbatim, to better uncover and understand what matters most to this patient population. They then used that information via a set of tools as well as personal insight to reach this goal.

The next steps include interviewing more patients and modifying their strategies for patients to get the most value from this research, ultimately increasing quality of life through their content.

Hernandez is also affiliated with CreakyJoints Español.

Related Videos
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
Shreena K. Gandhi, MBBS: Recognizing Fibromyalgia as a Continuous Variable, Trait Diagnosis
Reducing Treatment Burden of Pegloticase for Uncontrolled Gout, with Orrin Troum, MD
Exploring CAR T-cell Therapy for Rheumatic/Autoimmune Diseases With Georg Schett, MD
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
Uncovering the Role of COVID-19 in Rheumatic Disease, with Leonard Calabrese, DO
© 2024 MJH Life Sciences

All rights reserved.